Your browser doesn't support javascript.
loading
Vγ2 x PD-L1, a Bispecific Antibody Targeting Both the Vγ2 TCR and PD-L1, Improves the Anti-Tumor Response of Vγ2Vδ2 T Cell.
Yang, Rui; He, Qing; Zhou, Hui; Gong, Cheng; Wang, Xing; Song, Xingpan; Luo, Fang; Lei, Yang; Ni, Qian; Wang, Zili; Xu, Shasha; Xue, Yan; Zhang, Man; Wen, Haimei; Fang, Lijuan; Zeng, Liang; Yan, Yongxiang; Shi, Jian; Zhang, Jing; Yi, Jizu; Zhou, Pengfei.
Afiliação
  • Yang R; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • He Q; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Zhou H; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Gong C; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Wang X; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Song X; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Luo F; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Lei Y; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Ni Q; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Wang Z; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Xu S; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Xue Y; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Zhang M; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Wen H; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Fang L; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Zeng L; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Yan Y; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Shi J; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Zhang J; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Yi J; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
  • Zhou P; Department of Early Discovery and Research, Wuhan YZY Biopharma Co., Ltd, Wuhan, China.
Front Immunol ; 13: 923969, 2022.
Article em En | MEDLINE | ID: mdl-35784353
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Neoplasias Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Neoplasias Limite: Humans Idioma: En Revista: Front Immunol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China